Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Turn Therapeutics Inc. (TTRX) had Operating Cash Flow per Share of $-0.06 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-0.97M |
|
-- |
|
-- |
|
$1.25M |
|
$-1.25M |
|
$0.28M |
|
$-0.97M |
|
$-0.97M |
|
$-0.97M |
|
$-0.97M |
|
$-0.97M |
|
$-0.97M |
|
$-1.25M |
|
$-0.75M |
|
29.48M |
|
29.48M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$11.45M |
|
-- |
|
$7.19M |
|
$18.64M |
|
$5.13M |
|
$5.94M |
|
$7.40M |
|
$12.53M |
|
$6.12M |
|
$5.20M |
|
$6.12M |
|
29.79M |
|
| Cash Flow Statement Financials | |
$-1.63M |
|
$-0.01M |
|
$7.79M |
|
$5.08M |
|
$11.22M |
|
$6.14M |
|
$0.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.23 |
|
-- |
|
-- |
|
0.49 |
|
0.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.87% |
|
-18.68% |
|
-5.21% |
|
-8.06% |
|
$0.21 |
|
$-0.06 |
|
|
Operating Cash Flow per Share |
$-0.06 |